Cargando…

Increased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy

Rationale: Hypertrophic cardiomyopathy (HCM) occurs in ~0.5% of the population and is a leading cause of sudden cardiac death (SCD) in young adults. Cardiomyocyte hypertrophy has been the accepted mechanism for cardiac enlargement in HCM, but the early signaling responsible for initiating hypertroph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farrell, Emily T., Grimes, Adrian C., de Lange, Willem J., Armstrong, Annie E., Ralphe, J. Carter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470088/ https://www.ncbi.nlm.nih.gov/pubmed/28659827 http://dx.doi.org/10.3389/fphys.2017.00414

Ejemplares similares

Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling
por: Farrell, Emily, et al.
Publicado: (2018)

Altered coronary artery function, arteriogenesis and endothelial YAP signaling in postnatal hypertrophic cardiomyopathy
por: Langa, Paulina, et al.
Publicado: (2023)

Familial hypertrophic cardiomyopathy: functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development
por: Brenner, Bernhard, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Kawana, Masataka, et al.
Publicado: (2022)

Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Frontiers Production Office,
Publicado: (2022)

Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmia
por: Ripoll-Vera, Tomas, et al.
Publicado: (2018)

Hypertrophic cardiomyopathy: a heart in need of an energy bar?
por: Vakrou, Styliani, et al.
Publicado: (2014)

Classifying Cardiac Actin Mutations Associated With Hypertrophic Cardiomyopathy
por: Despond, Evan A., et al.
Publicado: (2018)

Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
por: Mekhaimar, Menatalla, et al.
Publicado: (2022)

Identification of hypertrophy-modulating Cullin-RING ubiquitin ligases in primary cardiomyocytes
por: Fischer, Maximillian, et al.
Publicado: (2023)

Periostin is overexpressed, correlated with fibrosis and differs among grades of cardiomyocyte hypertrophy in myectomy tissue of patients with hypertrophic cardiomyopathy
por: Ioakeimidis, Nikolaos S., et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation
por: Chalovich, J. M., et al.
Publicado: (2022)

Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model
por: Stücker, Sabrina, et al.
Publicado: (2017)

Regulation of myoglobin in hypertrophied rat cardiomyocytes in experimental pulmonary hypertension
por: Peters, E. L., et al.
Publicado: (2016)

Ablation of cardiac myosin–binding protein-C accelerates contractile kinetics in engineered cardiac tissue
por: de Lange, Willem J., et al.
Publicado: (2013)

Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy
por: Schlossarek, Saskia, et al.
Publicado: (2014)

Image-Based Computational Hemodynamics Analysis of Systolic Obstruction in Hypertrophic Cardiomyopathy
por: Fumagalli, Ivan, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy in Infants from the Perspective of Cardiomyocyte Maturation
por: Seok, Heeyoung, et al.
Publicado: (2021)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants
por: Kraker, Jessica, et al.
Publicado: (2016)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

Altered Ca(2+) and Na(+) Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis
por: Coppini, Raffaele, et al.
Publicado: (2018)

Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
por: Kresin, Nico, et al.
Publicado: (2019)

Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D
por: Herwig, Melissa, et al.
Publicado: (2020)

Mechanisms of Arrhythmogenicity in Hypertrophic Cardiomyopathy: Insight From Non-invasive Electrocardiographic Imaging
por: Perez-Alday, Erick A., et al.
Publicado: (2020)

Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy
por: Bollen, Ilse A. E., et al.
Publicado: (2017)

Subaortic and midventricular obstructive hypertrophic cardiomyopathy with extreme segmental hypertrophy
por: Efthimiadis, Georgios K, et al.
Publicado: (2007)

Extreme septal hypertrophy in an adolescent with congenital familial hypertrophic cardiomyopathy
por: Park, Byoung-Won, et al.
Publicado: (2015)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

ECG Abnormalities Preceding Structural Changes of Apical Hypertrophic Cardiomyopathy by up to 10 Years
por: McManus, Taylor, et al.
Publicado: (2023)

Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction
por: Zhao, Xiaodan, et al.
Publicado: (2018)

Numerical Simulation Study on the Mechanism of Formation of Apical Aneurysm in Hypertrophic Cardiomyopathy With Midventricular Obstruction
por: Deng, Long, et al.
Publicado: (2021)

Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
por: Chen, Gong, et al.
Publicado: (2018)

Investigations into the Sarcomeric Protein and Ca(2+)-Regulation Abnormalities Underlying Hypertrophic Cardiomyopathy in Cats (Felix catus)
por: Messer, Andrew E., et al.
Publicado: (2017)

Proteomic Analysis of Myocardia Containing the Obscurin R4344Q Mutation Linked to Hypertrophic Cardiomyopathy
por: Hu, Li-Yen R., et al.
Publicado: (2020)

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
por: Pioner, Josè Manuel, et al.
Publicado: (2022)

The effect of inhibition of the Na(+)/H(+) exchanger on the development of hypertrophy in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2011)

Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy
por: CIAMPI, QUIRINO, et al.
Publicado: (2006)

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
por: Monserrat, Lorenzo, et al.
Publicado: (2011)

Electro‐ and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
por: Bula, Karolina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2urb07cp0pd66lgaait1snonc6